Annual Drug Patent Expirations for VTAMA
Vtama is a drug marketed by Dermavant Sci and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has fifty-eight patent family members in thirty-six countries.
The generic ingredient in VTAMA is tapinarof. One supplier is listed for this compound. Additional details are available on the tapinarof profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Dermavant Sci drug VTAMA
You must log in to post a comment.